Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avadel Pharmaceuticals Plc (AVDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10085
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells its products in the US, France, and Ireland. The company operates in St. Louis, Missouri, and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc (AVDL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Avadel Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 11
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Flamel Technologies Enters Into Product Partnership Agreement With Pharma Company 13
Merger 14
Flamel Technologies Merges with Avadel Pharma 14
Licensing Agreements 15
Cerecor to Enter into Licensing Agreement with Avadel Ireland 15
Avadel Pharma to Enter into Licensing Agreement with Serenity Pharma for Noctiva 16
Perrigo Enters into Licensing Agreement with Flamel Ireland 18
Tris Pharma And FSC Labs Enter Into Licensing Agreement For Karbinal ER 19
Equity Offering 20
Flamel to Raise USD13.1 Million in Private Placement of Shares 20
Flamel Technologies Completes Public Offering Of Shares For US$121 Million 21
Debt Offering 23
Avadel Pharma Raises USD143.8 Million in Private Placement of 4.5% Notes Due 2023 23
Flamel Technologies Completes Private Placement Of Notes Due 2017 For US$15 Million 24
Asset Transactions 25
Cerecor Acquires Pediatric Business from Avadel Pharma 25
Aytu BioScience Acquires Rights to Primsol from FSC Labs for USD1.8 Million 27
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 28
Acquisition 30
Flamel Technologies Acquires FSC Holdings 30
Flamel Technologies Acquires Eclat Pharma For US$12 Million 32
Avadel Pharmaceuticals Plc – Key Competitors 34
Avadel Pharmaceuticals Plc – Key Employees 35
Avadel Pharmaceuticals Plc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 38
Financial Announcements 38
Nov 05, 2018: Avadel Pharmaceuticals reports third quarter 2018 financial results 38
Aug 07, 2018: Avadel Pharmaceuticals reports second quarter 2018 financial results 40
May 02, 2018: Avadel Pharmaceuticals Reports First Quarter 2018 Results 42
Mar 08, 2018: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results 44
Nov 08, 2017: Avadel Pharmaceuticals Reports Third Quarter 2017 Results 45
Aug 08, 2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results 47
May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 49
Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 50
Corporate Communications 52
Mar 22, 2018: Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer 52
Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 53
Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer 54
Clinical Trials 55
May 17, 2017: Avadel Pharmaceuticals Supports the Narcolepsy Network’s 5th Annual DREAM BIG Walk 55
Other Significant Developments 56
Dec 29, 2017: Avadel Pharmaceuticals Issues 2018 Corporate Outlook 56
Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update 58
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avadel Pharmaceuticals Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Avadel Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 11
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Flamel Technologies Enters Into Product Partnership Agreement With Pharma Company 13
Flamel Technologies Merges with Avadel Pharma 14
Cerecor to Enter into Licensing Agreement with Avadel Ireland 15
Avadel Pharma to Enter into Licensing Agreement with Serenity Pharma for Noctiva 16
Perrigo Enters into Licensing Agreement with Flamel Ireland 18
Tris Pharma And FSC Labs Enter Into Licensing Agreement For Karbinal ER 19
Flamel to Raise USD13.1 Million in Private Placement of Shares 20
Flamel Technologies Completes Public Offering Of Shares For US$121 Million 21
Avadel Pharma Raises USD143.8 Million in Private Placement of 4.5% Notes Due 2023 23
Flamel Technologies Completes Private Placement Of Notes Due 2017 For US$15 Million 24
Cerecor Acquires Pediatric Business from Avadel Pharma 25
Aytu BioScience Acquires Rights to Primsol from FSC Labs for USD1.8 Million 27
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 28
Flamel Technologies Acquires FSC Holdings 30
Flamel Technologies Acquires Eclat Pharma For US$12 Million 32
Avadel Pharmaceuticals Plc, Key Competitors 34
Avadel Pharmaceuticals Plc, Key Employees 35
Avadel Pharmaceuticals Plc, Subsidiaries 36

List of Figures
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Avadel Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SOLX Inc:医療機器:M&Aディール及び事業提携情報
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • iiNet Limited:企業の戦略・SWOT・財務情報
    iiNet Limited - Strategy, SWOT and Corporate Finance Report Summary iiNet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cardno Ltd:企業のM&A・事業提携・投資動向
    Cardno Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cardno Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Fresnillo Plc:企業の戦略・SWOT・財務情報
    Fresnillo Plc - Strategy, SWOT and Corporate Finance Report Summary Fresnillo Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Terna SpA (TRN):電力:M&Aディール及び事業提携情報
    Summary Terna SpA (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers special …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Bank of Montreal:企業の戦略・SWOT・財務分析
    Bank of Montreal - Strategy, SWOT and Corporate Finance Report Summary Bank of Montreal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Araca Energy ASA:石油・ガス:M&Aディール及び事業提携情報
    Summary Araca Energy ASA (Araca Energy), formerly Aladdin Oil & Gas Company ASA is an oil and gas company that explores, acquires, extracts, develops, and produces oil and gas assets in Russia and other countries. The company conducts its oil and gas exploration, production and operations through it …
  • REVA Medical Inc (RVA):医療機器:M&Aディール及び事業提携情報
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • European Bank for Reconstruction and Development:企業のM&A・事業提携・投資動向
    European Bank for Reconstruction and Development - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's European Bank for Reconstruction and Development Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Beiersdorf AG (BEI):企業の財務・戦略的SWOT分析
    Beiersdorf AG (BEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tissue Genesis Inc-医療機器分野:企業M&A・提携分析
    Summary Tissue Genesis Inc (TGI) is a biotechnology company that provides services in the area of tissue engineering and cell therapy solutions. The company’s products include tissue genesis cell isolation system and icellator cell isolation system. It offers services such as repair restore and reju …
  • JALUX Inc:企業の戦略・SWOT・財務情報
    JALUX Inc - Strategy, SWOT and Corporate Finance Report Summary JALUX Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GenePOC Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group, is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a n …
  • Jersey Oil and Gas Plc (JOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Jersey Oil and Gas Plc (Jersey Oil), formerly Trap Oil Group Plc is an upstream oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas properties in the UK continental shelf. Its oil and gas properties include Homer Block, Cortina Bl …
  • Nila Infrastructures Ltd
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Young Innovations Inc:医療機器:M&Aディール及び事業提携情報
    Summary Young Innovations Inc (Young Innovations), develops, manufactures and markets dental supplies and equipments to hygienists, dentists, dental assistants and consumers. The company offers various dental products and accessories such as disposable and metal prophylaxis angles, prophy cups and b …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆